4//SEC Filing
Gallagher Duncan 4
Accession 0001562180-25-000010
CIK 0001636422other
Filed
Jan 1, 7:00 PM ET
Accepted
Jan 2, 4:29 PM ET
Size
5.1 KB
Accession
0001562180-25-000010
Insider Transaction Report
Form 4
Gallagher Duncan
Director
Transactions
- Sale
Common Stock
2024-12-30$6.93/sh−4,500$31,184→ 69,938 total
Footnotes (1)
- [F1]The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on May 26, 2024 in accordance with Rule 10b5-1.
Documents
Issuer
Health Catalyst, Inc.
CIK 0001636422
Entity typeother
Related Parties
1- filerCIK 0001780880
Filing Metadata
- Form type
- 4
- Filed
- Jan 1, 7:00 PM ET
- Accepted
- Jan 2, 4:29 PM ET
- Size
- 5.1 KB